Dr. Mrinal Gounder is the Scientific Director of DTRF and a member of the Medical and Scientific Advisory Boards. He is a medical oncologist at MSKCC specializing in sarcomas and developing new drugs in cancer and specializes in desmoid tumors. He is an internationally recognized leader in desmoid tumors and has led numerous clinical trials in desmoid tumors. He led the phase 3, international studies of sorafenib and nirogacestat in desmoid tumors. In collaboration with DTRF, MSKCC, and IQVIA, he developed the GODDESS© patient reported outcomes tool – the first of its kind to evaluate the experience of patients with desmoid tumors.
Stay Up to Date as We Uncover More About Desmoid Tumors
Your Donation Changes Lives
Every donation, no matter the size, helps us continue our mission.
